Industry

Valence Labs

Part of Recursion Pharmaceuticals

Recursion's semi-autonomous AI research engine, advancing deep learning for drug discovery and building predictive models of cellular biology.

Location: Montreal, Canada
Website
1 model(1 Single-cell, 1 DNA & Gene)

Models (1)

TxPert

Valence Labs / Recursion Pharmaceuticals

Released May 20, 2025

Transcriptomic perturbation prediction across unseen single and double gene knockdowns and unseen cell lines, driven by gene-gene knowledge graphs.

Single-cellDNA & Gene